Our previous study revealed that DEPDC1 was exclusively associated with the PI3K/AKT/mTOR signaling pathway in breast cancer, and key genes involved in the activation of this pathway were enriched in patients with elevated DEPDC1 expression (28). Here, DEPDC1 is linked to breast cancer.